• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    DJO® Showcases Growing Foot & Ankle Portfolio at ACFAS Scientific Conference

    2/22/22 7:11:00 AM ET
    $CFX
    Fluid Controls
    Capital Goods
    Get the next $CFX alert in real time by email

    Through Recent Acquisitions and Internal Development, DJO makes its mark in the industry as a Foot & Ankle Business

    DJO®, a subsidiary of Colfax Corporation (NYSE:CFX) and a leading global provider of medical technologies to get and keep people moving, today announced it will showcase their growing Foot & Ankle offerings at the 2022 American College of Foot and Ankle Surgeons (ACFAS) Scientific Conference in Austin from February 21-24, 2022. DJO has created a dedicated foot and ankle business unit that expands the company's mission of Powering Motion.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220222005128/en/

    The DJO DynaNail Hybrid™ Fusion System features a unique dual design that combines the compressive power and stability of a nail with the easy insertion and anatomical friendliness of a screw. This system will be featured during the DJO Industry Workshop Thursday morning during ACFAS: Achieve Active Adaptive Healing with the New and Innovative DynaNail Hybrid. (Photo: Business Wire)

    The DJO DynaNail Hybrid™ Fusion System features a unique dual design that combines the compressive power and stability of a nail with the easy insertion and anatomical friendliness of a screw. This system will be featured during the DJO Industry Workshop Thursday morning during ACFAS: Achieve Active Adaptive Healing with the New and Innovative DynaNail Hybrid. (Photo: Business Wire)

    "The last 14 months have been focused on building an intentional set of Foot & Ankle offerings through acquisitions and internal development here at DJO and now, we are ready to introduce ourselves as a Foot & Ankle division in one of the fastest growing markets of orthopedics," said Gary Justak, President and General Manager of DJO's Foot & Ankle Division. "We are here to provide disruptive innovation, share our proven outcomes and listen to the Foot & Ankle surgeon for continuous improvement and development opportunities."

    DJO will highlight products from their foot and ankle continuum of care including:

    • DynaNail Hybrid™ Compressive power and stability of a nail with the easy insertion and anatomical friendliness of a screw.
    • DynaClip® – Nitinol Compression Staples
    • Arsenal Foot Plating System™: variable angle locking technology and dual lead screws
    • STAR® Total Ankle Replacement
    • Aircast ® AirSelect™ Walking Boot
    • DJO® Regeneration OL1000™ Bone Stimulation Device

    ACFAS Attendees have several opportunities throughout the week to experience these product offerings firsthand. Join one of the morning Industry Workshops, attend our Friday event customer event at The Eleanor Room, and visit Booth 104 in the Exhibit Hall. Registration links and more information can be found here: https://www.djoglobal.com/acfas

    About DJO

    DJO, a subsidiary of Colfax Corporation (NYSE:CFX), is a leading developer and distributor of high-quality medical devices that provide proven solutions for musculoskeletal health, joint reconstruction, vascular health, and pain management. The Company's extensive range of products and integrated technologies address the orthopedic continuum of care from performance and mobility to surgical intervention and post-operative rehabilitation, enabling people around the world to regain or maintain their natural motion. For additional information about DJO, please visit www.DJOGlobal.com.

    MK-10236

    View source version on businesswire.com: https://www.businesswire.com/news/home/20220222005128/en/

    Get the next $CFX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CFX

    DatePrice TargetRatingAnalyst
    3/2/2022$8.00 → $7.00Sector Perform
    RBC Capital
    2/23/2022$58.00 → $52.00Buy
    Stifel
    2/8/2022Buy → Neutral
    Seaport Global
    1/28/2022$51.00 → $45.00Equal-Weight
    Morgan Stanley
    1/14/2022$56.00 → $51.00Equal-Weight
    Morgan Stanley
    1/6/2022$45.00Hold
    Loop Capital
    11/5/2021$57.00 → $60.00Overweight
    Keybanc
    10/20/2021$12.00 → $9.00Outperform → Sector Perform
    RBC Capital
    More analyst ratings

    $CFX
    SEC Filings

    View All

    Colfax Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Enovis CORP (0001420800) (Filer)

    6/30/22 8:23:02 AM ET
    $CFX
    Fluid Controls
    Capital Goods

    SEC Form 11-K filed by Colfax Corporation

    11-K - Enovis CORP (0001420800) (Filer)

    6/29/22 3:02:16 PM ET
    $CFX
    Fluid Controls
    Capital Goods

    Colfax Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - Enovis CORP (0001420800) (Filer)

    6/13/22 4:14:55 PM ET
    $CFX
    Fluid Controls
    Capital Goods

    $CFX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital reiterated coverage on Canfor Pulp Products with a new price target

    RBC Capital reiterated coverage of Canfor Pulp Products with a rating of Sector Perform and set a new price target of $7.00 from $8.00 previously

    3/2/22 7:16:55 AM ET
    $CFX
    Fluid Controls
    Capital Goods

    Stifel reiterated coverage on Colfax with a new price target

    Stifel reiterated coverage of Colfax with a rating of Buy and set a new price target of $52.00 from $58.00 previously

    2/23/22 8:55:36 AM ET
    $CFX
    Fluid Controls
    Capital Goods

    Colfax downgraded by Seaport Global

    Seaport Global downgraded Colfax from Buy to Neutral

    2/8/22 6:36:17 AM ET
    $CFX
    Fluid Controls
    Capital Goods

    $CFX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Kleckner John sold $2,496 worth of shares (44 units at $56.73), decreasing direct ownership by 3% to 1,661 units (for tax liability)

    4 - Enovis CORP (0001420800) (Issuer)

    7/21/22 8:00:15 PM ET
    $CFX
    Fluid Controls
    Capital Goods

    SEC Form 4: Perfall A Clayton was granted 432 shares, increasing direct ownership by 1% to 31,073 units

    4 - Enovis CORP (0001420800) (Issuer)

    7/1/22 7:00:22 PM ET
    $CFX
    Fluid Controls
    Capital Goods

    SEC Form 4: Lalor Angela S was granted 319 shares, increasing direct ownership by 16% to 2,363 units

    4 - Enovis CORP (0001420800) (Issuer)

    7/1/22 7:00:17 PM ET
    $CFX
    Fluid Controls
    Capital Goods

    $CFX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Enovis (formerly Colfax) Completes Spin-off of ESAB Corporation

    Wilmington, DE, April 05, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation ("Enovis" or the "Company") (NYSE:ENOV), an innovation-driven medical technology growth company formerly known as Colfax Corporation, announced today the completion of its previously announced separation (the "Separation") of its fabrication technology business into an independent, publicly traded company, ESAB Corporation ("ESAB") (NYSE:ESAB). Immediately following the Separation, Enovis effected its previously announced reverse stock split of all issued and outstanding shares of Enovis common stock at a one-for-three ratio. Enovis and ESAB common stock will each begin regular-way trading today, April 5, 2022, on t

    4/5/22 6:00:00 AM ET
    $CFX
    Fluid Controls
    Capital Goods

    ESAB Set to Join S&P MidCap 400; PROG Holdings to Join S&P SmallCap 600

    NEW YORK, March 30, 2022 /PRNewswire/ -- ESAB Corp. (NYSE:ESAB) will be added to the S&P MidCap 400 effective prior to the opening of trading on Tuesday, April 5. Effective prior to the opening of trading on Wednesday, April 6, S&P MidCap 400 constituent PROG Holdings Inc. (NYSE:PRG) will replace Fiesta Restaurant Group Inc. (NASD: FRGI) in the S&P SmallCap 600. S&P MidCap 400 constituent Colfax Corp. (NYSE:CFX) is spinning off ESAB in a transaction expected to be completed on April 5. Post spin-off, Colfax will be renamed Enovis Corp. (NYSE:ENOV) and will remain in the S&P MidCap 400. PROG Holdings is more representative of the small-cap market space and Fiesta Restaurant Group is no longer

    3/30/22 8:21:00 PM ET
    $CFX
    $FRGI
    $PRG
    Fluid Controls
    Capital Goods
    Restaurants
    Consumer Discretionary

    Colfax Announces Board of Directors for Post-Spinoff ESAB

    Wilmington, DE, March 28, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE:CFX), a leading diversified technology company which will renamed Enovis Corporation ("Enovis") following the expected April 4, 2022 consummation of the Company's previously announced spin-off of its fabrication technology business (the "Separation"), which will operate as ESAB Corporation ("ESAB") after the Separation, today announced the future composition of the full ESAB Board of Directors (the "Board"). Following the Separation, Mitchell P. Rales will serve as chairman of the Board, and current Colfax directors Patrick W. Allender, Rhonda L. Jordan, Didier Teirlinck and Rajiv Vinnakota will serve as directo

    3/28/22 6:30:00 AM ET
    $CFX
    Fluid Controls
    Capital Goods

    $CFX
    Financials

    Live finance-specific insights

    View All

    Colfax Corporation Announces Fourth Quarter and Full Year 2021 Results

    Strong operating performance supported $0.06 EPS from continuing operations and $0.59 of adjusted EPSAchieved a strong quarter of cash flow, contributing to full year operating cash flow of $356 million and free cash flow of $277 millionPositioned for separation into two independent public companies near the end of the first quarter 2022 with strong growth outlooks for both businesses Wilmington, DE, Feb. 22, 2022 (GLOBE NEWSWIRE) --  Colfax Corporation (NYSE:CFX), a leading diversified technology company, today announced its financial results for the fourth quarter and fiscal year 2021 and provided additional updates. The Company reported fourth quarter net income from c

    2/22/22 6:00:00 AM ET
    $CFX
    Fluid Controls
    Capital Goods

    Colfax Schedules Fourth Quarter and Fiscal Year 2021 Earnings Release and Conference Call

          Wilmington DE, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE:CFX), a leading diversified technology company, today announced that it will issue a press release providing financial results for the fourth quarter and fiscal year 2021 on the morning of Tuesday, February 22, 2022. The Company will hold a conference call to discuss these results beginning at 8:00 a.m. Eastern on that day, which will be open to the public by calling +1-877-303-7908 (U.S. callers) and +1-678-373-0875 (International callers) and referencing the conference ID number 7466839 and through webcast via Colfax's website www.colfaxcorp.com under the "Investors" section. Colfax's financial results

    1/20/22 5:00:23 PM ET
    $CFX
    Fluid Controls
    Capital Goods

    Colfax Corporation Announces Third Quarter 2021 Results

                                                   Posted $0.17 EPS from continuing operations and $0.54 of adjusted EPSIncreased sales 20% to $966 million including a 15% organic sales-per-day improvementReported strong progress on integration of acquisitionsAnnounced continued progress to Q1 2022 separation including new post-separation name for MedTech growth company WILMINGTON, DE, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE:CFX), a leading diversified technology company, today announced its financial results for the third quarter of 2021 and provided other updates. The Company reported third quarter net income from continuing operations of $27 million, or $0

    11/4/21 6:00:00 AM ET
    $CFX
    Fluid Controls
    Capital Goods

    $CFX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Colfax Corporation

    SC 13G - Enovis CORP (0001420800) (Subject)

    4/21/22 3:32:21 PM ET
    $CFX
    Fluid Controls
    Capital Goods

    SEC Form SC 13G/A filed by Colfax Corporation (Amendment)

    SC 13G/A - Colfax CORP (0001420800) (Subject)

    3/11/22 2:13:51 PM ET
    $CFX
    Fluid Controls
    Capital Goods

    SEC Form SC 13G/A filed by Colfax Corporation (Amendment)

    SC 13G/A - Colfax CORP (0001420800) (Subject)

    2/9/22 3:43:31 PM ET
    $CFX
    Fluid Controls
    Capital Goods